Skip to main content

Table 3 Clinical outcomes, complications and mortality of the burn patients

From: Quantifying the impact of inhalational burns: a prospective study

  Non-inhalational burns n = 167 Inhalational burns n = 35 p value, U
Number of surgery sessions, median (IQR) 1 (1–1) 3 (0–10) 0.003, U = 3552
Length of stay (days), median (IQR) 8 (5–12) 21 (4–43) 0.004, U = 3582
Average length of stay/%TBSA (sum of length of stay/sum of %TBSA) 1.307 0.976 NA
Length of ICU stay (days), median (IQR) 0 (0–0) 3 (0–10) < 0.001, U = 4785
Average length of ICU stay/%TBSA (sum of length of ICU stay/sum of %TBSA) 0.020 0.313 NA
Days on IV antibiotics, median (IQR) 3 (1–6) 9.5 (0–28.25) 0.014, U = 3552
Average days on IV antibiotics/%TBSA (Sum of days of IV antibiotics/sum of %TBSA) 0.580 0.474 NA
Days of mechanical ventilation, median (IQR) 0 (0–0) 2 (0–10) < 0.001
Initial P/F ratio, median (IQR) 532.6 (316.8–678.9) 370.4 (291.8–554.2) 0.191
Lowest P/F ratio in 2 days from admission, median (IQR) 518.5 (372.0–689.5) 253.6 (202.7–408.4) 0.026
Lowest P/F ratio in 7 days from admission, median (IQR) 518.5 (372.0–689.5) 246.8 (181.5–389.4) 0.018
Admission to HD, n (%) 46 (27.5) 31(88.6) < 0.001
Admission to ICU, n (%) 10 (6.0) 22 (62.9) < 0.001
Intubation, n (%) 4 (2.4) 22 (62.8) < 0.001
Mortality, n (%) 1 (0.6) 6 (17.1) < 0.001
AKI, n (%) 2 (1.2) 13 (37.1) < 0.001
ARDS, n (%) 1 (0.6) 17 (48.6) < 0.001
Bacteraemia, n (%) 4 (2.4) 11 (31.4) < 0.001
Pneumonia, n (%) 2 (1.2) 13 (37.1) < 0.001
Burn wound infection, n (%) 42 (25.1) 18 (51.4) 0.004
  1. %TBSA percentage of total body surface area, ARDS acute respiratory distress syndrome, AKI acute kidney injury, IV intravenous, ICU intensive care unit, NA not applicable, HD high dependency unit, IQR interquartile range, P/F PaO2 /FiO2